Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Csernansky

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Topics in Behavioral Neurosciences|February 12, 2011
Thalamic pathology in schizophreniaWill J Cronenwett, John Csernansky
Clinical Psychological Science : a Journal of the Association for Psychological Science|December 9, 2014
Altered cognitive development in the siblings of individuals with schizophreniaDeanna M Barch, Rachel Cohen, John Csernansky
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 14, 2008
A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophreniaJeffrey A Lieberman, Kelly Papadakis, John Csernansky, et al.
Schizophrenia Research|December 12, 2001
Does cognitive function improve with quetiapine in comparison to haloperidol?Dawn I Velligan, John Newcomer, Joseph Pultz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 26, 2010
What have we learned about trial design from NIMH-funded pragmatic trials?John March, Helena C Kraemer, Madhukar Trivedi, et al.
Journal of Clinical Psychopharmacology|July 26, 2019
Monthly Extended-Release Risperidone (RBP-7000) in the Treatment of Schizophrenia: Results From the Phase 3 ProgramAnne Andorn, Jay Graham, John Csernansky, et al.
Biological Psychology|June 16, 2015
Neural substrates of negativity bias in women with and without major depressionJackie K Gollan, Megan Connolly, Angel Buchanan, et al.
Behavioural Brain Research|November 25, 2010
Structural pathology underlying neuroendocrine dysfunction in schizophreniaMorris B Goldman, Lei Wang, Carly Wachi, et al.
Neuroimage|July 7, 2007
Combining anatomical manifold information via diffeomorphic metric mappings for studying cortical thinning of the cingulate gyrus in schizophreniaAnqi Qiu, Laurent Younes, Lei Wang, et al.
Psychoneuroendocrinology|February 26, 2018
Corticotrophin releasing factor receptor 1 antagonists prevent chronic stress-induced behavioral changes and synapse loss in aged ratsHongxin Dong, Jack M Keegan, Ellie Hong, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Topics in Behavioral Neurosciences|February 12, 2011
Thalamic pathology in schizophreniaWill J Cronenwett, John Csernansky
Clinical Psychological Science : a Journal of the Association for Psychological Science|December 9, 2014
Altered cognitive development in the siblings of individuals with schizophreniaDeanna M Barch, Rachel Cohen, John Csernansky
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 14, 2008
A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophreniaJeffrey A Lieberman, Kelly Papadakis, John Csernansky, et al.
Schizophrenia Research|December 12, 2001
Does cognitive function improve with quetiapine in comparison to haloperidol?Dawn I Velligan, John Newcomer, Joseph Pultz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 26, 2010
What have we learned about trial design from NIMH-funded pragmatic trials?John March, Helena C Kraemer, Madhukar Trivedi, et al.
Journal of Clinical Psychopharmacology|July 26, 2019
Monthly Extended-Release Risperidone (RBP-7000) in the Treatment of Schizophrenia: Results From the Phase 3 ProgramAnne Andorn, Jay Graham, John Csernansky, et al.
Biological Psychology|June 16, 2015
Neural substrates of negativity bias in women with and without major depressionJackie K Gollan, Megan Connolly, Angel Buchanan, et al.
Behavioural Brain Research|November 25, 2010
Structural pathology underlying neuroendocrine dysfunction in schizophreniaMorris B Goldman, Lei Wang, Carly Wachi, et al.
Neuroimage|July 7, 2007
Combining anatomical manifold information via diffeomorphic metric mappings for studying cortical thinning of the cingulate gyrus in schizophreniaAnqi Qiu, Laurent Younes, Lei Wang, et al.
Psychoneuroendocrinology|February 26, 2018
Corticotrophin releasing factor receptor 1 antagonists prevent chronic stress-induced behavioral changes and synapse loss in aged ratsHongxin Dong, Jack M Keegan, Ellie Hong, et al.
Pageof 2